The BioSpring Advantage
BioSpring, an industry-leading expert in nucleic acid science and technology, delivers therapeutic-quality oligonucleotides at all production scales, spanning the complete drug development lifecycle. Our aim is a highly collaborative partnership to unleash the full potential of our clients' technology - accelerating breakthrough therapies to meet their commercial promise.
Clients can rely on our precision and strict cGMP compliance – guided by expertise, passion for innovation and more than 27 years of experience.
From one Source
At Any Scale
We support our clients from early small-/mid-scale manufacture of their drug development candidates to late-stage clinical and commercial manufacturing, including all related analytical activities.
- cGMP manufacturing for clinical Phase I – III: Multiple-hundred kg annual capacity
- Process validation and commercial manufacture
- Manufacturing of nucleic acids for R&D, as well as lead candidate screening and development
- Process development – more than 140 successful programs each year
- Scale-up, scale-down and process transfer
- Pre-clinical non-GMP batch manufacture
- Regulatory tox batch manufacture
- Generation of reference standards
Nucleic Acid Manufacturing and analysis
Unleash the full potential of your nucleic acid programs! Contact us
